Inventor · disambiguated record
Kieu Lam
Also filed as: LAM KIEU · LAM KIEU MONG
10 granted patents·19 pending applications·1,068 citations·filing 2006–2025
92Inventor score
Files withARBUTUS BIOPHARMA CORP11GENEVANT SCIENCES GMBH9PROTIVA BIOTHERAPEUTICS INC5YAWORSKI EDWARD2MACLACHLAN IAN1
Top patents by PatentIndex Score
29 records- 0198US11141378B2Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2021·Granted Oct 12, 2021·42 cites·30 claims
- 0298US9364435B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·194 cites·20 claims
- 0398US8822668B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Sep 2, 2014·99 cites·23 claims
- 0498US8492359B2Lipid formulations for nucleic acid deliveryYAWORSKI EDWARD·Filed 2011·Granted Jul 23, 2013·109 cites·21 claims
- 0598US8058069B2Lipid formulations for nucleic acid deliveryYAWORSKI EDWARD·Filed 2009·Granted Nov 15, 2011·585 cites·22 claims
- 0695US11191849B2Compositions and methods for delivering messenger RNAARBUTUS BIOPHARMA CORP·Filed 2017·Granted Dec 7, 2021·10 cites·10 claims
- 0793US9005654B2Systems and methods for manufacturing liposomesMACLACHLAN IAN·Filed 2006·Granted Apr 14, 2015·29 cites·16 claims
- 0888US2023372245A1Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 0978US2020113832A1Novel lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 1077US2021220274A1Novel lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 1172US2025281422A1Cationic lipids containing siliconARBUTUS BIOPHARMA CORP·Filed 2025·Application pending·0 cites
- 1269US12350383B2Cationic lipids containing siliconARBUTUS BIOPHARMA CORP·Filed 2019·Granted Jul 8, 2025·0 cites·9 claims
- 1368US2018092848A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1467US2018085312A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1566US2022160899A1Compositions and methods for delivering messenger rnaARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 1665US2025332112A1Ionizable cationic lipids for lipid nanoparticlesGENEVANT SCIENCES GMBH·Filed 2023·Application pending·0 cites
- 1763US2024148663A1Peg lipids and lipid nanoparticlesGENEVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 1863US2024216545A1Mrna delivery constructs and methods of using the sameGENEVANT SCIENCES GMBH·Filed 2022·Application pending·0 cites
- 1963US2017042814A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2061US2025114476A1Poly(alkyloxazoline)-lipid conjugates and lipid particles containing sameGENEVANT SCIENCES GMBH·Filed 2023·Application pending·0 cites
- 2156US2023001021A1Ornithine transcarbamylase (otc) constructs and methods of using the samePRIEVE MARY·Filed 2020·Application pending·0 cites
- 2256US2023150926A1Cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cellsGENEVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 2356US2024065982A1Lipid nanoparticles for delivering therapeutics to lungsGENEVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 2455US12357705B2Negatively charged peg-lipid conjugatesARBUTUS BIOPHARMA CORP·Filed 2019·Granted Jul 15, 2025·0 cites·20 claims
- 2554US12251470B2Lipid nanoparticle formulationsARBUTUS BIOPHARMA CORP·Filed 2019·Granted Mar 18, 2025·0 cites·10 claims
- 2654US2022031847A1Therapeutic methodsGENEVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 2753US2023139594A1Cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cellsGENEVANT SCIENCES GMBH·Filed 2021·Application pending·0 cites
- 2851US2022168222A1Lipid nanoparticlesGENEVANT SCIENCES GMBH·Filed 2020·Application pending·0 cites
- 2948US2022001029A1Lipid nanoparticle formulationsARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kieu Lam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →